Literature DB >> 15694417

Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice.

Zhiyuan Zhang1, Thomas Welte, Nancy Troiano, Stephen E Maher, Xin-Yuan Fu, Alfred L M Bothwell.   

Abstract

Hematopoietic cell-specific disruption of the STAT3 gene induces hyperproliferation of cells of the myeloid lineage. Osteoclasts (OC), the bone-resorbing cells, are generated from the same precursors as monocyte/macrophages. STAT3 mutant mice exhibit decreased bone density, bone volume, and increased numbers of TRAP-positive OC. In vitro generation of OC showed significantly greater numbers of OC in mutant mice. The increased numbers of Mac1+ cells and c-kit+ cells were detected by FACS analysis, suggesting an increased number of OC precursors. Treatment of splenocytes with CSF-1 and RANKL significantly increased the Mac-1+RANK+ cells, with much higher levels observed in cells from mutant mice compared with littermate controls. Besides enhanced number of Mac1+ OC precursors, we also identified an OC-generating Mac1- c-kit+ population in mutant mice which was absent in littermate controls. The Mac1- c-kit- cells did not generate OC. Finally, we determined that protein expression and mRNA level of c-fos, a transcription factor which is essential for OC differentiation, were enhanced in OC precursors of mutant mice, which may contribute to the osteopenic phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694417     DOI: 10.1016/j.bbrc.2005.01.019

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

Review 1.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

2.  Bone density and fractures in autosomal dominant hyper IgE syndrome.

Authors:  Kathryn J Sowerwine; Pamela A Shaw; Wenjuan Gu; Jennifer C Ling; Michael T Collins; Dirk N Darnell; Victoria L Anderson; Joie Davis; Amy Hsu; Pamela Welch; Jennifer M Puck; Steven M Holland; Alexandra F Freeman
Journal:  J Clin Immunol       Date:  2014-01-09       Impact factor: 8.317

3.  Reduced bone density in patients with autosomal dominant hyper-IgE syndrome.

Authors:  Oded Scheuerman; Vered Hoffer; Avner Herman Cohen; Cristina Woellner; Bodo Grimbacher; Ben-Zion Garty
Journal:  J Clin Immunol       Date:  2013-04-19       Impact factor: 8.317

Review 4.  The hyper-IgE syndromes.

Authors:  Alexandra F Freeman; Steven M Holland
Journal:  Immunol Allergy Clin North Am       Date:  2008-05       Impact factor: 3.479

5.  Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.

Authors:  Ellen D Renner; Stacey Rylaarsdam; Stephanie Anover-Sombke; Anita L Rack; Janine Reichenbach; John C Carey; Qili Zhu; Annette F Jansson; Julia Barboza; Lena F Schimke; Mark F Leppert; Melissa M Getz; Reinhard A Seger; Harry R Hill; Bernd H Belohradsky; Troy R Torgerson; Hans D Ochs
Journal:  J Allergy Clin Immunol       Date:  2008-07       Impact factor: 10.793

Review 6.  Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.

Authors:  Alexandra F Freeman; Steven M Holland
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

7.  Capric acid inhibits NO production and STAT3 activation during LPS-induced osteoclastogenesis.

Authors:  Eun-Jung Park; Sun A Kim; Yong-Min Choi; Hyuk-Kwon Kwon; Wooyoung Shim; Gwang Lee; Sangdun Choi
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

8.  Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3.

Authors:  Cindy S Ma; Gary Y J Chew; Nicholas Simpson; Archana Priyadarshi; Melanie Wong; Bodo Grimbacher; David A Fulcher; Stuart G Tangye; Matthew C Cook
Journal:  J Exp Med       Date:  2008-07-07       Impact factor: 14.307

9.  IL-6 Induction by TNFα and IL-1β in an Osteoblast-Like Cell Line.

Authors:  Elena Confalone; Giuseppe D'Alessio; Adriana Furia
Journal:  Int J Biomed Sci       Date:  2010-06

Review 10.  Pathogenesis of hyper IgE syndrome.

Authors:  Jennifer Heimall; Alexandra Freeman; Steven M Holland
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.